N1H-Cloud and LeishGen showcased at London Calling 2024
The Nano1Health team attended London Calling 2024, the Oxford Nanopore Technologies user meeting, on 22 and 23 May 2024.
Industrial PhD candidate Marina Carrasco presented a poster on drug-resistance biomarkers in Leishmania infantum using nanopore sequencing and structural-variant analysis. It received a Highly Commended distinction.
We showed LeishGenApp and LeishGenR™, developed over two years within a Neotec project supported by CDTI. We sequenced 46 Leishmania infantum isolates from dogs and humans with nanopore technology, reaching 98.4% average genome completeness, and LeishGenApp found resistance markers for five common drugs in 89% of the isolates.
Torres Quevedo postdoctoral researcher Joan Martí-Carreras presented N1H-Cloud, our web platform for nanopore data in One Health research. It includes LeishGenApp, N1H-Assemblatron for genome assembly, N1H-Amplitron for 16S barcoding and, coming soon, the N1H-Metagenomics classifier.
Questions about this news? Write to info@nano1health.com.